Your browser doesn't support javascript.
loading
The experience with colorectal cancer screening in the Czech Republic: the detection at earlier stages and improved clinical outcomes.
Kral, J; Kojecky, V; Stepan, M; Vladarova, M; Zela, O; Knot, J; Jakovljevic, M; Kralova, Z; Buresova, R; Grega, T; Bauman, D; Kotyza, J; Stepanova, R; Hucl, T; Vodicka, P; Vodickova, L; Spicak, J.
Afiliación
  • Kral J; Institute for Clinical and Experimental Medicine, Department of Gastroenterology and Hepatology, Prague, Czech Republic; Department of Molecular Biology of Cancer, Institute of Experimental Medicine, The Czech Academy of Sciences, Prague, Czech Republic. Electronic address: jan.kral@centrum.cz.
  • Kojecky V; T. Bata Hospital, Gastroenterology Department, Zlin, Czech Republic.
  • Stepan M; Vitkovice Hospital, Gastroenterology Department, Vitkovice, Czech Republic.
  • Vladarova M; Brno University Hospital, Gastroenterology Department, Brno, Czech Republic.
  • Zela O; Frydek-Mistek Hospital, Gastroenterology Department, Frydek-Mistek, Czech Republic.
  • Knot J; Klaudian Hospital, Gastroenterology Department, Mlada Boleslav, Czech Republic.
  • Jakovljevic M; Gastroenterology Private Practice, Hluboka Nad Vltavou, Czech Republic.
  • Kralova Z; Medic Kral, Ltd., Gastroenterology Private Practice, Prague, Czech Republic.
  • Buresova R; Chomutov Hospital, Gastroenterology Department, Chomutov, Czech Republic.
  • Grega T; Military University Hospital, Gastroenterology Department, Prague, Czech Republic.
  • Bauman D; Masaryk Hospital, Gastroenterology Department, Rakovnik, Czech Republic.
  • Kotyza J; University Hospital Plzen, Gastroenterology Department, Plzen, Czech Republic.
  • Stepanova R; International Clinical Research Centre of St. Anne's University Hospital, Brno, Czech Republic.
  • Hucl T; Institute for Clinical and Experimental Medicine, Department of Gastroenterology and Hepatology, Prague, Czech Republic.
  • Vodicka P; Department of Molecular Biology of Cancer, Institute of Experimental Medicine, The Czech Academy of Sciences, Prague, Czech Republic; Faculty of Medicine and Biomedical Center in Pilsen, Pilsen and First Medical Faculty, Prague, Charles University, Czech Republic.
  • Vodickova L; Department of Molecular Biology of Cancer, Institute of Experimental Medicine, The Czech Academy of Sciences, Prague, Czech Republic; Faculty of Medicine and Biomedical Center in Pilsen, Pilsen and First Medical Faculty, Prague, Charles University, Czech Republic. Electronic address: ludmila.vodicko
  • Spicak J; Institute for Clinical and Experimental Medicine, Department of Gastroenterology and Hepatology, Prague, Czech Republic.
Public Health ; 185: 153-158, 2020 Aug.
Article en En | MEDLINE | ID: mdl-32634606
OBJECTIVES: Colorectal cancer (CRC) remains a major health burden. Although screening is recommended and considered beneficial, further data on its positive effects are needed for worldwide implementation. STUDY DESIGN: The aim of our national multicentre prospective observational study was to reveal and document clinicopathological differences in CRC diagnosed by screening and presented by disease symptoms as well as assess the efficiency of the screening programme in the Czech Republic. METHODS: Between March 2013 and September 2015, a total of 265 patients were enrolled in 12 gastroenterology centres across the Czech Republic. Patients were divided into screening and symptomatic groups and compared for pathology status and clinical characteristics. Screening was defined as a primary screening colonoscopy or a colonoscopy after a positive faecal occult blood test in an average-risk population. RESULTS: The distribution of CRC stages was significantly (statistically and clinically) favourable in the screening group (predominance of stages 0, I and II) compared with the non-screening group (P < 0.001). The presence of distant and local metastases was significantly less frequent in the screening group than in the symptomatic group (P < 0.001). Patients in the screening group had a higher probability of radical surgery (R0) than those diagnosed based on symptoms (P < 0.001). Systemic palliative treatment was indicated in two patients in the screening group compared with 23 patients in the non-screening group (P = 0.018). CONCLUSION: CRC diagnosed by screening disclosed less advanced clinicopathological characteristics and results in patients with a higher probability of radical surgery (R0) than diagnoses established based on symptoms, with subsequent management differing accordingly between both groups. These results advocate the implementation of a suitable worldwide screening programme.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Tamizaje Masivo / Detección Precoz del Cáncer Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Public Health Año: 2020 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Tamizaje Masivo / Detección Precoz del Cáncer Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Public Health Año: 2020 Tipo del documento: Article Pais de publicación: Países Bajos